Jerusalem, 16 April, 2026 (TPS-IL) — Israeli fertility tech firm FertilAI has secured CE marking under the European Union’s Medical Device Regulation, allowing its AI-driven clinical decision support tools to be marketed across the EU after meeting safety, health and performance standards.
The Tel Aviv-based company said its Fertilane platform integrates with existing clinic systems and uses data from more than 100,000 cycles to guide decision-making. Its StimAI and OvuPredict algorithms help forecast optimal trigger timing, ovulation and expected oocyte yields, aiming to improve IVF outcomes and streamline clinic workloads.